Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:41:24.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now includes an expanded Locations section with new study sites in Pordenone and Turin, updating where the trial is conducted. The footer item HHS Vulnerability Disclosure was removed (a minor change) and the revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T10:15:22.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no changes to core content or user-facing data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:56:04.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.3.1 is now shown on the page, replacing the previous Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T13:40:12.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding status notice banner that warned users about potential delays in updates and responses. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:29:02.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page content appears unchanged; there are no updates to study details between versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:10:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.